S&P 500 Aiming Higher on Vaccine Progress Despite Gridlock Fears

The S&P 500 index may continue to rise on positive Covid-19 vaccine developments despite Senate Majority Leader Mitch McConnell’s push for a skinny fiscal aid package.

Related Articles

Responses

Your email address will not be published. Required fields are marked *